Do Imaging Core Laboratories Better Predict Progression Over Clinical Interpretations?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Do Imaging Core Laboratories Better Predict Progression Over Clinical Interpretations?

Published:2023-09-01 Issue:5 Volume:5 Page:
ISSN:2638-616X
Container-title:Radiology: Imaging Cancer
language:en
Short-container-title:Radiology: Imaging Cancer

Author:

Margolis Daniel J. A.¹^ORCID,Ruchalski Kathleen L.¹^ORCID

Affiliation:

1. From the Department of Radiology, Weill Cornell Medical College, 525 E 68th St, Box 141, New York, NY 10068 (D.J.A.M.); and Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Calif (K.L.R.).

Publisher

Radiological Society of North America (RSNA)

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/rycan.230092

Reference8 articles.

1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

2. Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations

3. Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP